Media Contact:
Dan Budwick
Pure Communications, Inc.
(973) 271-6085OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care ConferenceGaithersburg, Md. – November 30, 2010 – OpGen, Inc. a commercial phase genomics company, today announced that Douglas White, chief executive officer, is scheduled to present at the Piper Jaffray 22nd Annual Health Care Conference on Wednesday, Dec. 1, 2010, at 1:30 p.m. in New York City.About OpGen, Inc.
OpGen, Inc. is a leading innovator in the f...
Media Contact:
Dan Budwick
Pure Communications, Inc.
(973) 271-6085Gaithersburg, Md. – November 4, 2010 – BGI, the largest genomics organization in the world, and OpGen, Inc., a commercial phase genomics company and exclusive provider of Optical Mapping Technology, announced their joint effort to expand the use of Optical Mapping for de novo sequence finishing in human, plant and animal genomes.BGI and OpGen have successfully completed a study based on human genome data to close gaps in the e...
Names Evan Jones as Executive Chairman of the BoardMedia Contact:
Dan Budwick
Pure Communications, Inc.
(973) 271-6085Gaithersburg, Md. – September 27, 2010 – OpGen, Inc., a commercial phase genomics company, today announced the successful completion of a $17 million Series B equity financing. The new round of financing was led by jVen Capital with participation from the company’s other major investors, including CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Vers...
